Hypoactive Sexual Desire Disorder: Clinical Trials

42 trials for Hypoactive Sexual Desire Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

33 completed, 4 terminated, 2 not yet recruiting, 2 unknown. 16 Phase 3, 9 Phase 2, 8 Not applicable, 4 Phase 4, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 316Completed 16
Phase 29Completed 7, Not yet recruiting 2
Not applicable8Completed 6, Terminated 1, Unknown 1
Phase 44Completed 2, Terminated 1, Unknown 1
Phase 12Not yet recruiting 1, Terminated 1

Follow Hypoactive Sexual Desire Disorder: new trials by email Literature Review of Hypoactive Sexual Desire Disorder trials Research Report on Hypoactive Sexual Desire Disorder

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
Aromatase Inhibitors, Bupropion, GnRH agonist - Early-stage Breast Cancer, Hypoactive Sexual Desire Disorder
Phase 1 / Phase 2Not yet recruitingUniversity of Illinois at Chicago1002026-09-012026-08-24
An Open-Label Study of 50 Mg Oral Testosterone Undecanoate (Kyztrex) in Menopausal Women with Low Testosterone and HSDD
Oral Testosterone Undecanoate - Hypoactive Sexual Desire Disorder
Phase 2Not yet recruitingSan Diego Sexual Medicine302025-01-012024-11-13
A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal)
Bremelanotide, Placebo - Hypoactive Sexual Desire Disorder
Phase 3CompletedKwang Dong Pharmaceutical co., ltd.1932021-05-102024-11-13
Improving Female Sexual Wellness
Vibrator - Sexuality, Sexual Dysfunction
Not applicableCompletedCedars-Sinai Medical Center862021-04-102023-04-06
A Mindfulness-based Intervention for Older Women With Low Sexual Desire
mindfulness-based multicomponent intervention, general health education group - Hypoactive Sexual Desire Disorder, Sexual Dysfunction
Not applicableCompletedUniversity of Pittsburgh622020-10-082022-10-13
Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder
Bremelanotide, Placebo - Hypoactive Sexual Desire Disorder
Phase 4CompletedImperial College Healthcare NHS Trust402019-10-072024-08-09
Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters.
Testosterone gel, Estradiol ovules, Moisturizer - Hypoactive Sexual Desire Disorder, Vulvovaginal Disease
CompletedUniversity of Florence812019-03-202020-04-07
Waitlist Controlled Comparison of Cognitive-behavioral vs. Mindfulness-based Online-treatments for Women With Low Sexual Desire
Cognitive-behavioral treatment, Mindfulness-based treatment - Hypoactive Sexual Desire Disorder
Not applicableCompletedRuhr University of Bochum2662018-12-182023-03-29
BP101 for Adults With Female Sexual Dysfunction
BP101, Placebo - Hypoactive Sexual Desire Disorder, Female Sexual Dysfunction
Phase 3CompletedIvix LLX2052018-03-052020-02-11
Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)
Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal Insert - Hypoactive Sexual Desire Disorder
Phase 3CompletedEndoCeutics Inc.6532017-10-162021-04-09
Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy
sex therapy, flibanserin - Hypoactive Sexual Desire Disorder
Phase 4TerminatedSan Diego Sexual Medicine232017-01-252022-06-13
Effects of Flibanserin on the Pre- and Post-menopausal Female Brain
Flibanserin, Placebo - Hypoactive Sexual Desire Disorder
Not applicableTerminatedUniversity of Chicago572016-10-012024-05-16
Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women
Vaginal progesterone 8% - Menopause, Sexual Desire Disorder
Phase 4UnknownBezmialem Vakif University302016-07-012017-10-20
A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women
Placebo vulvar cream, Estradiol vulvar cream - Hypoactive Sexual Desire Disorder
Not applicableCompletedProHealth Care, Inc302016-04-012020-03-13
Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men
Bupropion hydrochloride sustained-release, placebo - Sexual Dysfunctions, Psychological, Hypoactive Sexual Desire Disorder
Phase 2CompletedUniversity of Malaya802015-12-012019-08-01
2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
Bremelanotide, Placebo - Hypoactive Sexual Desire Disorder
Phase 3CompletedPalatin Technologies, Inc7142015-01-012021-01-28
The Effect of Individualised Homeopathic Treatment on Low Sexual Desire in Perimenopause
Sucrose pillules medicated with the Individualised Homeopathic Remedy - Hypoactive Sexual Desire Disorder
Phase 2CompletedUniversity of Johannesburg102015-01-012016-05-17
1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder
Bremelanotide, Placebo - Hypoactive Sexual Desire Disorder
Phase 3CompletedPalatin Technologies, Inc7232014-12-012021-04-09
Low Sexual Desire and Metabolic Syndrome
Female sexual function index questionnaire, Evaluation of presence of metabolic syndrome, Evaluation of the body mass index - Menopause, Metabolic Syndrome
Not applicableCompletedFaculdade de Ciências Médicas da Santa Casa de São Paulo2912014-09-012022-10-12
Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder
Placebo, 0.5 mgTestosterone + 10 mg Buspirone - Hypoactive Sexual Desire Disorder
Phase 2CompletedEmotional Brain NY Inc.802013-07-012015-03-24

Showing 20 of 42. Sign in to see all of them.

Narrower conditions

Sexual Dysfunctions, Psychological (42)  ·  Sexual Dysfunction, Physiological (7)  ·  Erectile Dysfunction (3)  ·  Breast Neoplasms (2)  ·  Dyspareunia (2)  ·  Coitus (1)  ·  Cystitis, Interstitial (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Metabolic Syndrome (1)  ·  Obesity (1)  ·  Orgasm (1)  ·  Pelvic Floor Disorders (1)  ·  Pelvic Organ Prolapse (1)

Broader conditions

Mental Disorders (42)  ·  Genital Diseases (9)  ·  Urogenital Diseases (9)  ·  Behavior (5)  ·  Male Urogenital Diseases (5)  ·  Genital Diseases, Male (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Sexual Behavior (3)  ·  Breast Diseases (2)  ·  Genital Diseases, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Sexual Dysfunction, Physiological (2)

Interventions

Testosterone (5)  ·  bremelanotide (5)  ·  Testosterone Propionate (3)  ·  Bupropion (2)  ·  Buspirone (2)  ·  Dehydroepiandrosterone (2)  ·  flibanserin (2)  ·  Anastrozole (1)  ·  Aromatase Inhibitors (1)  ·  Estradiol (1)  ·  Ginkgo Extract (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Goserelin (1)  ·  Intrinsa (1)  ·  Letrozole (1)

Sponsors

Warner Chilcott (6)  ·  BioSante Pharmaceuticals (4)  ·  Emotional Brain NY Inc. (3)  ·  Palatin Technologies, Inc (3)  ·  Imperial College Healthcare NHS Trust (2)  ·  San Diego Sexual Medicine (2)  ·  Beersheva Mental Health Center (1)  ·  Bezmialem Vakif University (1)  ·  Cedars-Sinai Medical Center (1)  ·  Center for Epidemiology and Health Research, Germany (1)  ·  EndoCeutics Inc. (1)  ·  Faculdade de Ciências Médicas da Santa Casa de São Paulo (1)  ·  Hadassah Medical Organization (1)  ·  Ivix LLX (1)  ·  Kwang Dong Pharmaceutical co., ltd. (1)

Countries

United States (25)  ·  Canada (11)  ·  Australia (4)  ·  Germany (3)  ·  United Kingdom (3)  ·  Israel (2)  ·  Botswana (1)  ·  Brazil (1)  ·  Italy (1)  ·  Malaysia (1)  ·  Russia (1)  ·  South Africa (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)

Top investigators

Michael C Snabes, MD, PhD (4)  ·  Johna Lucas, MD (3)  ·  Irwin Goldstein, MD (2)  ·  Robert Jordan (2)  ·  Anne Yee (1)  ·  Aviv M Weinstein, Ph.D (1)  ·  Cindy Meston, PhD (1)  ·  Claude Labrie, M.D., Ph.D. (1)  ·  Daniil G. Nemenov, MD (1)  ·  Eyal Shif, Prof. MD (1)  ·  Imran A Lodhi, MD (1)  ·  Janice Pellow, M.TechHom (1)  ·  Jeffrey Edelson, MD, FRCPC (1)  ·  John C Stevenson, MBBS (1)

Results publications

PMID 10782451, PMID 28189361, PMID 31599840, PMID 31599847, PMID 33033885, PMID 33538638, PMID 35147466, PMID 36809187, PMID 18987368, PMID 22172433, PMID 23084789, PMID 23875721, PMID 27181790, PMID 31745959, PMID 32593675, PMID 32990248, PMID 34118018, PMID 34559353, PMID 36189794, PMID 39446648

NIH funding

K23AG052628 (1), R01HD051676 (1)